First Pediatric Pyeloplasty Using the Senhance® Robotic System—A Case Report

Autor: Juergen Holzer, Peter Beyer, Florian Schilcher, Clemens Poth, Dietmar Stephan, Christian von Schnakenburg, Wim van Gemert, Ludger Staib

Publikováno v: Children, Vol 9, Iss 3, p 302 (2022)

A pediatric robotic pyeloplasty has been performed with the Senhance® robotic system for the first time in January 2021 on a 1.5-year-old girl with symptomatic ureteropelvic junction stenosis. A Senhance® robotic system (Asensus Surgical® Inc., Du

Externí odkaz: https://doaj.org/article/60eebfbac864422a8d207841ba3010a7

The long-term influence of hospital and surgeon volume on local control and survival in the randomized German Rectal Cancer Trial CAO/ARO/AIO-94

Autor: Tim Beißbarth, Werner Hohenberger, Thilo Sprenger, Michael Ghadimi, Hans-Rudolf Raab, Rolf Sauer, Ludger Staib, Jorg Tschmelitsch, Rainer Fietkau, Claus Rödel

Publikováno v: Surgical Oncology. 35:200-205

Background The association of treatment volume and oncological outcome of rectal cancer patients undergoing multidisciplinary treatment is subject of an ongoing debate. Prospective data on long-term local control and overall survival (OS) are not ava

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65eec4f48ba29b12daf97ba906661900
https://doi.org/10.1016/j.suronc.2020.08.021

Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12

Autor: Claus Rödel, Anke Schlenska-Lange, Tim Friede, Anca-Ligia Grosu, Emmanouil Fokas, Rainer Fietkau, Michael Flentje, Wolff Schmiegel, Michael Allgäuer, Wolf O. Bechstein, Thomas Brunner, Gunther Klautke, Matthias Schwarzbach, Gerhard G. Grabenbauer, G. Folprecht, Jürgen Weitz, Bülent Polat, Ludger Staib, Thomas Kuhnt, Ralf-Dieter Hofheinz, L. Jacobasch, Vittorio Paolucci, Christoph-Thomas Germer, Michael Ghadimi, Robert Grützmann

Publikováno v: Journal of Clinical Oncology. 37:3212-3222

PURPOSE Total neoadjuvant therapy is a new paradigm for rectal cancer treatment. Optimal scheduling of preoperative chemoradiotherapy (CRT) and chemotherapy remains to be established. PATIENTS AND METHODS We conducted a multicenter, randomized, phase

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c64b97daff7604261622cb6c5c8f63d9
https://doi.org/10.1200/jco.19.00308

Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer

Autor: Bülent Polat, Dagmar Burchert, Werner Hohenberger, Christoph Müller-Leisse, Michael Geißler, Andreas Rosenwald, Elisabeth Rösler, Wolfgang Bank, Kay C. Willborn, Gunther Klautke, Helmut Gnann, Oliver Kölbl, Thomas Brunner, Christian Stroszczynski, Heinrich Wiesinger, Gunnar Folprecht, Ute Küchenmeister, Kirsten Papsdorf, Hagen Flach, Bernd Rosin, Matthias Schwarzbach, Guido Hildebrandt, Ursula Pession, Sanja Schmeck, Richard Viehbahn, Timo Gaiser, Michael Henke, Christof Lamberti, Robert Grützmann, Detlef Imhoff, Michael J. Eble, Peter Bronsert, Wolf O. Bechstein, Thorsten Jacobi, Bernhard Leibl, Elisabeth Germer, Claus Rödel, Wolfgang Wendt, Martin-Leo Hansmann, Jens Freiberg-Richter, Henning Schäfer, Gerhard G. Grabenbauer, Wolff Schmiegel, Peter Kappl, Harold Ortloff, Andrea Tannapfel, Nicolas Moosmann, Christiane Lange, Philipp Manegold, Vittorio Paolucci, Olaf Dirsch, Klaus Kirchhof, Michael Allgäuer, Jan Braess, Markus Zachäus, Irenäus Adamietz, Rainer Fietkau, Michael Ghadimi, Guido Woeste, Hans Jürgen Schlitt, L. Jacobasch, Ulrike Attenberger, Simon Kirste, Ulrich Halm, Godehard Lahmer, Jochen Gaedcke, Andreas Gschwendtner, Michael Flentje, Christine Volkheimer, Andreas Erbesdolber, Philipp Bruners, Jörn Sträter, Stephan Falk, Manfred Dörne, Jörg Olaf Habeck, Ulrich Stölzel, Claus-Henning Köhne, Christoph-Thomas Germer, Lutz Renziehausen, Rolf-Peter Henke, Stefan Post, Ludger Staib, Popiliu Piso, Monika Warmuth-Metz, Volker Kunzmann, Christian Wittekind, Peter Wild, Thomas Kittner, Marga Lang-Welzenbach, Tom Lüdde, Martin Eichel, Dietrich Meißner, Joachim Boese-Land, Marcel Binnebösel, Frank Griesinger, Ruth Knüchel-Clarke, Ralf-Dieter Hofheinz, Eckhardt Schneider, Giovanna Römer, Ulrich Kania, Tim Friede, Klaus Holzweißig, Thorsten Bley, Felix Steger, Stefan Krämer, Anca-Ligia Grosu, Emmanouil Fokas, Michael Pohl, Ernst Klar, Heiko Sülberg, Nils Habbe, Petra Hödl, Andre Serebrennikov, Anke Schlenska-Lange, Thomas Kuhnt, Katica Krajinovic, Ullrich Graeven, Thomas Schmidt, Stephan Sahm, Gustavo Baretton, Ulrike Ubbelohde, Kirsten Merx, Ferdinand Hofstädter, Frederik Wenz, Christian Möllecken, Hannes Philipp Neeff

Publikováno v: JAMA Oncol

Importance Total neoadjuvant therapy has been increasingly adopted for multimodal rectal cancer treatment. The optimal sequence of chemoradiotherapy (CRT) and chemotherapy needs to be established. Objective To report the long-term results of the seco

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e04cd2e279e369e20381feb63851ae9d
https://doi.org/10.1001/jamaoncol.2021.5445

Adjuvant Chemotherapy of Locally Advanced Colon Cancer: Final Results of a Randomized Trial Comparing 5-Fluorouracil and Folinic Acid with Folfiri

Autor: Roland Goeb, Doris Henne-Bruns, Holger Hebart, Stephan Paschke, Ullrich Fleck, Ludger Staib, Marko Kornmann, Silvia Sander, Karl-Heinrich Link

Publikováno v: Visceral medicine. 35(2)

Background: There is still the need to optimize adjuvant treatment of colon cancer (CC). Standard adjuvant chemotherapy using 5-fluorouracil (FU) and folinic acid (FA) was compared with a combination including irinotecan (Folfiri). The aim of the pre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f39540c9e20df3a538267e221b86faf
https://pubmed.ncbi.nlm.nih.gov/31192246